We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health Aratana Reports Voting Results from 2019 Special Meeting of Stockholders PR Newswire LEAWOOD, Kan., July 16...
TÜBINGEN, Germany and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced that Timothy...
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial Commercial availability of NOCITA 10 mL vial size anticipated by fall 2019 PR...
Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders Stockholders Elect All Class III Directors and Approve Proposals PR Newswire LEAWOOD, Kan., June 7, 2019...
Aratana Therapeutics Reports First Quarter 2019 Financial Results Continued revenue growth across portfolio of marketed pet therapeutics PR Newswire LEAWOOD, Kan., May 8, 2019 LEAWOOD, Kan., May...
Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference PR Newswire LEAWOOD, Kan., May 7, 2019 LEAWOOD, Kan., May 7, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc. PR Newswire NEW YORK, April 26, 2019 NEW YORK, April 26, 2019 /PRNewswire/ -- Rowley Law PLLC is...
Elanco announces investor call for 9:00 am today Elanco Animal Health (NYSE:ELAN) today announced it has signed an agreement to acquire Aratana Therapeutics (NASDAQ:PETX), a pet...
Aratana Therapeutics to be Acquired by Elanco Animal Health Elanco announces formation of commercial team dedicated to veterinary specialty business PR Newswire LEAWOOD, Kan., April 26, 2019...
Aratana Therapeutics to Report First Quarter 2019 Financial Results PR Newswire LEAWOOD, Kan., April 22, 2019 LEAWOOD, Kan., April 22, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions